Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Receivables Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Myriad Genetics (MYGN) Pension (2016)

Myriad Genetics (MYGN) has disclosed Pension for 2 consecutive years, with $6.1 million as the latest value for Q3 2016.

Quarterly Pension rose 24.49% to $6.1 million in Q3 2016 from the year-ago period, while the trailing twelve-month figure was $6.1 million through Sep 2016, up 24.49% year-over-year, with the annual reading at $5.9 million for FY2016, 20.41% up from the prior year.
Pension for Q3 2016 was $6.1 million at Myriad Genetics, up from $5.9 million in the prior quarter.
The five-year high for Pension was $6.1 million in Q3 2016, with the low at $4.8 million in Q4 2015.